Rosetta Genomics
Data Collection & Internet Portals · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10 Plaut St, Rehovot, Central District, ...Phone Number
+972 732220700Website
www.rosettagenomics.comRevenue
$10.1 MillionStock Symbol
ROSGQIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Rosetta Genomics
RosettaGenomics specializes in providing information and resources related to cancer. Their blog offers insights into cancer treatment, healthy living tips, and the complexities of cancer as a disease. The intended clients include individuals seeking knowledge about cancer and its management. They aim to educate and raise awareness about cancer-related issues.Explore more
Rosetta Genomics Org Chart
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rosetta Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Rosetta Genomics recently announced quarterly report
Click to see if Rosetta Genomics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Rosetta Genomics
Rosetta Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Rosetta Genomics is spiking on competitors!
Funding: Get notified immidiatlly once Rosetta Genomics has new funding data
Check if Rosetta Genomics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Rosetta Genomics launches new products
Recommended Actions
Reach out to Masked Content who joined Rosetta Genomics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Rosetta Genomics is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
Rosetta Genomics is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about Rosetta Genomics.
Rosetta Genomics financials insights
Gather financial insights about Rosetta Genomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Stock Offering
$26.3M
Rosetta Genomics Tech Stack
A closer look at the technologies used by Rosetta Genomics
See more technologies
Rosetta Genomics News & Media
Global Personalized Medicine Market to 2024: Personalized Cancer Therapy Gets a Boost from Patient-Derived Tumor Organoids
Dublin, Oct. 15, 2018 (GLOBE NEWSWIRE) -- The "Global Personalized Medicine Market - Types, Technologies and Applications" report has been added to ResearchAndMarkets.com's offering.Global Personalized Medicines Strategic Business Report 2018: Annual Estimates & Forecasts 2016-2024
Dublin, May 23, 2018 (GLOBE NEWSWIRE) -- The "Personalized Medicines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Rosetta Announces Resignation of CEO
PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 10, 2018 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, today announced that Kenneth Berlin will resign as President and CEO effective April 18, 2018 to pursue other opportunities. Mr. Berlin will assist management in a smooth transition with ongoing projects. Brian Markison, Chairman of the Board of Rosetta commAction Required Before Potential Bankruptcy
- If Shareholders Do Not Approve the Merger, Outstanding Ordinary Shares Likely Will Cease to Have Any Value - Price Per Ordinary Share Increased to an Estimated $0.42 - $0.50 - This is a New Shareholder Meeting and All Shareholders of Record as of March 20, 2018 Need to Vote Again Regardless of Whether They Voted at the Previous Extraordinary Meeting of Shareholders Held in February 2018 PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE /
Read more news
Top Data Collection & Internet Portals Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rosetta Genomics
Sign Up For FreeTo access detailed company insights
RosettaGenomics specializes in providing information and resources related to cancer. Their blog offers insights into cancer treatment, healthy living tips, and the complexities of cancer as a disease. The intended clients include individuals seeking knowledge about cancer and its management. They aim to educate and raise awareness about cancer-rel... Read More
